QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 限定条件 发表日期：2019     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A phase I, randomized, double-blinded, single-dose study evaluating the pharmacokinetic equivalence of the biosimilar IBI305 and bevacizumab in healthy male subjects 期刊论文 INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 卷号: 57, 期号: 3 作者:  Li, Cuiyun;  Zhang, Hong;  Zhu, Xiaoxue;  Wei, Haijing;  Chen, Hong 收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05 biosimilar  phase I  IBI305  bevacizumab  pharmacokinetics   Human papillomavirus type 18/16 infection and prevalence among middle-aged and older Chinese rural women: a cross-sectional survey in Wufeng, Hubei Province 期刊论文 WOMEN & HEALTH, 2019, 卷号: 59, 期号: 10 作者:  Yu, Qiuli;  Liu, Qing;  Gao, Yanduo;  Gong, Huiyun;  Tan, Xiaodong 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 HPV  behaviors  rural women  China   Preparation and Evaluation of Liposomes Co-Loaded with Doxorubicin, Phospholipase D Inhibitor 5-Fluoro-2-Indolyl Deschlorohalopemide (FIPI) and D-Alpha Tocopheryl Acid Succinate (-TOS) for Anti-Metastasis 期刊论文 2019, 卷号: 14, 期号: 1, 页码: 138 作者:  Song, Maoyuan;  Wang, Jiaxing;  Lei, Jiongxi;  Peng, Guanghua;  Zhang, Wenxi 收藏  |  浏览/下载：33/0  |  提交时间：2020/01/03 FIPI  DOX  -TOS  Liposomes  Anti-metastasis